IPOPLUS

₹746.15

▲ +0.45 +0.06%

18 Jun 2026

NSE Listed · Pharmaceuticals

Alembic Pharma Ltd. (APLLTD)

Volume: 3,845Avg Vol 1W: 82,401Avg Vol 1M: 1,13,18452W Range:₹635.8₹1,107.9
NSE BSE
₹746.15▲ 0.06%
Key Ratios
Updated just now
Market Cap₹14,607 Cr
Current Price₹746.15
Previous Close₹745.7
High / Low (52w)₹1,107.9 / ₹635.8
Volume3,845
Avg Vol (1W)82,401
Avg Vol (1M)1,13,184
Stock P/E31.31
Book Value₹288.72
Dividend Yield1.61%
ROE11.89%
ROA7.66%
Revenue (TTM)—
Revenue Growth7.12%
Profit Margin9.19%
Total Debt₹0 Cr
Shares Outstanding20 Cr
Face Value₹2
EPS (TTM)₹10.31
P/B2.73
Debt / Equity0.25
50 DMA₹747.85
200 DMA₹742.53
Day change+0.06%
Price Chart
₹746.15▼ 20.20% · 1Y
₹966₹64640.1L
2025-10-21
2026-06-16

20-day avg volume: 1.2L shares

Pros
  • Pays a dividend yield of 1.6%.
  • Company is almost debt-free.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹1,848 Cr₹1,876 Cr₹1,910 Cr₹1,711 Cr₹1,770 Cr₹1,693 Cr₹1,648 Cr₹1,562 Cr₹1,517 Cr₹1,631 Cr₹1,595 Cr₹1,486 Cr₹1,406 Cr₹1,509 Cr₹1,475 Cr₹1,262 Cr₹1,416 Cr₹1,272 Cr₹1,292 Cr₹1,326 Cr₹1,280 Cr₹1,314 Cr₹1,457 Cr₹1,341 Cr₹1,207 Cr
EBITDA₹165 Cr₹229 Cr₹247 Cr₹214 Cr₹217 Cr₹200 Cr₹186 Cr₹170 Cr₹194 Cr₹200 Cr₹151 Cr₹144 Cr₹139 Cr₹183 Cr₹165 Cr₹-51 Cr₹47 Cr₹201 Cr₹205 Cr₹185 Cr₹294 Cr₹321 Cr₹403 Cr₹366 Cr₹284 Cr
Net Profit₹203 Cr₹133 Cr₹185 Cr₹154 Cr₹157 Cr₹138 Cr₹153 Cr₹135 Cr₹178 Cr₹180 Cr₹137 Cr₹121 Cr₹153 Cr₹122 Cr₹133 Cr₹-66 Cr₹22 Cr₹172 Cr₹164 Cr₹165 Cr₹251 Cr₹293 Cr₹333 Cr₹301 Cr₹225 Cr
EPS10.316.769.47.857.987.017.796.849.079.236.956.147.766.26.78-3.351.118.748.348.3712.7514.8817.2415.9911.93
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹6,715 Cr₹6,257 Cr₹5,655 Cr₹5,356 Cr₹5,480 Cr₹4,611 Cr
EBITDA₹772 Cr₹689 Cr₹436 Cr₹638 Cr₹1,384 Cr₹1,071 Cr
Net Profit₹583 Cr₹616 Cr₹342 Cr₹521 Cr₹1,147 Cr₹829 Cr
EPS29.6831.3317.426.559.1843.97
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹7,773 Cr₹6,446 Cr₹6,183 Cr₹7,122 Cr₹6,709 Cr₹5,989 Cr
Total Liabilities₹2,583 Cr₹1,627 Cr₹1,812 Cr₹1,884 Cr₹1,642 Cr₹2,799 Cr
Equity₹5,190 Cr₹4,818 Cr₹4,370 Cr₹5,238 Cr₹5,067 Cr₹3,190 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹200 Cr₹887 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹159 Cr₹823 Cr₹785 Cr₹676 Cr₹1,709 Cr₹685 Cr
Investing₹-568 Cr₹-321 Cr₹-448 Cr₹-372 Cr₹-839 Cr₹-732 Cr
Financing₹444 Cr₹-438 Cr₹-262 Cr₹-217 Cr₹-597 Cr₹155 Cr
Free Cash Flow₹159 Cr₹823 Cr₹785 Cr₹676 Cr₹1,709 Cr₹685 Cr
Shareholding
Promoter 69.74% Institutions 20.43% Public 9.83%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search